New FDA Drug Chief: ‘Revolving Door’ or Reformer?

(MedPage Today) — Did George Tidmarsh, MD, PhD, enter the FDA through the very revolving door its new leadership pledged to close?
The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary…